-
1
-
-
0030850123
-
Risk factors for venous thrombosis: Prevalence, risk, and interaction
-
Rosendaal FR: Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol 1997;34(3):171-187
-
(1997)
Semin Hematol
, vol.34
, Issue.3
, pp. 171-187
-
-
Rosendaal, F.R.1
-
2
-
-
0030757385
-
Oral contraceptives and thrombotic disease: Risk of venous thromboembolism
-
Helmerhorst FM, Bloemenkamp KM, Rosendaal FR, et al: Oral contraceptives and thrombotic disease: risk of venous thromboembolism. Thromb Haemost 1997;78(1):327-333
-
(1997)
Thromb Haemost
, vol.78
, Issue.1
, pp. 327-333
-
-
Helmerhorst, F.M.1
Bloemenkamp, K.M.2
Rosendaal, F.R.3
-
3
-
-
0003984768
-
-
Montvale, NJ, Medical Economics Company, Inc
-
Physicians' Desk Reference, ed 52. Montvale, NJ, Medical Economics Company, Inc, 1998, pp 2013-2020
-
(1998)
Physicians' Desk Reference, Ed 52
, pp. 2013-2020
-
-
-
4
-
-
0029564931
-
Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study
-
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995;346(8990):1575-1582
-
(1995)
Lancet
, vol.346
, Issue.8990
, pp. 1575-1582
-
-
-
5
-
-
0030733181
-
The pill and thrombosis: Epidemiological considerations
-
Carter C: The pill and thrombosis: epidemiological considerations. Baillieres Clin Obstet Gynaecol 1997;11(3):565-585
-
(1997)
Baillieres Clin Obstet Gynaecol
, vol.11
, Issue.3
, pp. 565-585
-
-
Carter, C.1
-
6
-
-
0028029477
-
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
-
Vandenbroucke JP, Koster T, Briet E, et al: Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344(8935):1453-1457
-
(1994)
Lancet
, vol.344
, Issue.8935
, pp. 1453-1457
-
-
Vandenbroucke, J.P.1
Koster, T.2
Briet, E.3
-
7
-
-
0029948169
-
Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: Prevalence of factor V Leiden
-
Hirsch DR, Mikkola KM, Marks PW, et al: Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden. Am Heart J 1996;13(6):1145-1148
-
(1996)
Am Heart J
, vol.13
, Issue.6
, pp. 1145-1148
-
-
Hirsch, D.R.1
Mikkola, K.M.2
Marks, P.W.3
-
8
-
-
0030724266
-
Third-generation oral contraceptive and deep venous thrombosis; from epidemiologic controversy to new insight in coagulation
-
Vandenbroucke JP, Helmerhorst FM, Bloemenkamp KM, et al: Third-generation oral contraceptive and deep venous thrombosis; from epidemiologic controversy to new insight in coagulation. Am J Obstet Gynecol 1997;177(4):887-891
-
(1997)
Am J Obstet Gynecol
, vol.177
, Issue.4
, pp. 887-891
-
-
Vandenbroucke, J.P.1
Helmerhorst, F.M.2
Bloemenkamp, K.M.3
-
9
-
-
0029007585
-
Current concepts of anticoagulation therapy
-
Hull RD, Pineo GF: Current concepts of anticoagulation therapy. Clin Chest Med 1995;16(2):269-280
-
(1995)
Clin Chest Med
, vol.16
, Issue.2
, pp. 269-280
-
-
Hull, R.D.1
Pineo, G.F.2
|